According to the Global Burden of Disease Study, chronic respiratory diseases, including asthma and COPD, they accounted for 4.9 thousand deaths globally in 2019. The high prevalence rate of chronic disease increases the demand for implantable ports. Therefore, the global implantable ports market is estimated to increase rapidly in the near future.
Access Full Report @ https://www.databridgemarketresearch.com/ar/reports/global-implantable-ports-market
Data Bridge Market Research analyses that the Implantable Ports Market is expected to grow at a CAGR of 7.8% in the forecast period of 2023 to 2030 and is expected to reach USD 868,391.52 thousand by 2030. The growing demand for minimally invasive procedures is projected to propel the growth of the market as they involve smaller incisions and specialized tools, resulting in reduced surgical trauma compared to traditional open surgeries.
Key Findings of the Study
The increasing prevalence of chronic diseases is expected to drive the market's growth rate
Chronic diseases require long-term medication administration, often through Intravenous (IV) therapies. Implantable ports provide a convenient and reliable way to administer medications directly into the bloodstream. These ports can be accessed repeatedly, eliminating the need for frequent needle sticks and reducing patient discomfort. The growing prevalence of chronic diseases such as cancer, cardiovascular diseases, and end-stage renal diseases necessitates using implantable ports, thereby driving market growth.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2020
|
|
Historic Years
|
2021(Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in Thousand Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Single Lumen, Double Lumen, and Power-Injectable), By Material (Polyurethane, Silicone, Titanium, and Others), By Application (Chemotherapy, Blood Transfusion, Antibiotics, Intravenous Infusion of Blood Product, Pain Management, and Others), By End Users (Hospitals, Clinics, Ambulatory Surgical Centre, Dialysis Centers, and Others)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia and New Zealand, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
B. Braun SE (Germany), AngioDynamics (U.S.), B.D. (U.S.), Teleflex Incorporated. (U.S.), Vygon (France), ICU Medical, Inc (U.S.), PakuMedmedical products gmbh(Germany), and others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The implantable ports market is segmented on the basis of type, material, application, and end users.
- On the basis of type, the global implantable ports market is segmented into single lumen, double lumen, and power-injectable.
In 2023, the single lumen segment of type segment is anticipated to dominate the implantable ports market
In 2023, the single lumen segment of this market will dominate the implantable ports market owing to the increasing demand for minimally invasive procedures. The single lumen segment is expected to reach the highest CAGR of 9.2% in the forecast period of 2023-2030.
- On the basis of material, the global implantable ports market is segmented into polyurethane, silicone, titanium, and others. In 2023, the polyurethane segment is expected to dominate the market with a 47.88% market share due to its excellent biocompatibility feature
- On the basis of application, the global implantable ports market is segmented into chemotherapy, blood transfusion, antibiotics, intravenous infusion of blood product, pain management, and others. In 2023, the chemotherapy segment is expected to dominate with 42.70% market share due to the rising prevalence of cancer worldwide
- On the basis of end user, the global implantable ports market is segmented into hospitals, clinics, ambulatory surgical center, dialysis centers, and others. In 2023, the hospitals segment is expected to dominate the market with a 37.54% market share due to rising demand for minimally invasive procedures
In 2023, the hospitals segment is projected to hold the largest share of end user segment in the implantable ports market
In 2023, the hospitals segment holds the maximum market share as a higher number of patients prefer to visit hospitals for different cases such as chemotherapy, antibiotics, blood infusion and others. The hospital segment is growing with a CAGR of 9.6% in the forecast period of 2023 to 2030.
Major Players
Data Bridge Market Research recognizes the following companies as the major implantable ports market players in the implantable ports market B. Braun SE (Germany), AngioDynamics (U.S.), B.D. (U.S.), Teleflex Incorporated. (U.S.), and Vygon (France), ICU Medical, Inc (U.S.), PakuMedmedical products gmbh(Germany), and others.
Market Development
- In November 2022, Teleflex Incorporated announced that it was named a MedReps.com 2023 Best Places to Work, earning the Number 1 spot for large companies and making this the sixth consecutive year the company has been on the list. This will help the organization in developing brand image, among others
- In November 2022, Teleflex Incorporated announced that it had participated in the 33rd Annual Virtual Piper Sandler Healthcare Conference. This will help the organization in developing brand image, among others
- In September 2022, ICU Medical, Inc acquired the Smiths Medical division from Smiths Group plc. The addition of Smiths Medical syringe and ambulatory infusion devices, vascular access, and vital care products into ICU Medical creates a leading infusion therapy company with a stronger global reach
- In May 2022, AngioDynamics announced that it had participated in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum. This will increase the company’s brand image globally.
- In 2020, B.D. introduced the Bard Port Implantable Port System. This system is designed to provide reliable and long-term access for patients requiring repeated infusion therapies, such as chemotherapy, blood products, or antibiotics. This has helped the company to establish its global presence
Regional Analysis
Geographically, the countries covered in the implantable ports market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia and New Zealand, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis
North America is the dominant region in the implantable ports market during the forecast period 2023 - 2030
In 2023, North America dominated the implantable ports market owing to the higher level of investments by the U.S. manufacturers and the increasing prevalence of cancer in the U.S. North America will continue to dominate the implantable ports market in terms of market share and market revenue, and will continue to flourish its dominance during the forecast period. This is due to the growing adoption of advanced technology and the launch of new products in this region. Additionally, the increasing number of cases of chronic disease and the rising geriatric population is expected further to enhance the market growth rate in this region.
North America is estimated to be the fastest growing region in the implantable ports market in the forecast period 2023 - 2030
North America is expected to grow during the forecast period due to the presence of major market players and the rapid development of medical facilities in emerging economies in this region. In addition, rising healthcare expenditure levels and increasing per-capita income are expected to propel the market's growth rate in this region.
For more detailed information about the surgical visualization products market report, click here – https://www.databridgemarketresearch.com/ar/reports/global-implantable-ports-market
